UK unveils new health security strategy

Non-hormonal menopause treatment wins FDA nod

UK generics body wants in on VPAS talks

Confidence in childhood vaccines declines

Spoonful of technology

Spotlight: January-April 2023

Bold goals outlined for US bioeconomy

Pfizer acquires Seagen in $43bn deal

Spoonful of technology

Spotlight: December 2022–January 2023

Eli Lilly improves cold chain capacity

Fear for pharma growth prospects

Genomics identified as most impactful pharma trend

Pharma voted second most trusted industry in Britain

Moderna becomes latest ABPI member

HBA names 2023 Woman of the Year

Potential blockbuster drug front runners highlighted

ROI in R&D declines sharply in 2022

RSV drug nirsevimab chases FDA approval

Spoonful of technology